This trial will test the effects of dronabinol, a medication derived from marijuana, on people with opioid addiction who are receiving methadone or buprenorphine. The study will measure pain sensitivity, attentional bias, negative affect, and cognitive performance.
3 Primary · 3 Secondary · Reporting Duration: up to 6 hours
36 Total Participants · 5 Treatment Groups
Primary Treatment: Dronabinol 20mg · Has Placebo Group · Phase < 1
Age 18 - 70 · All Participants · 8 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: